Related Links Educational Materials About Clinical Trials Clinical Trials Questions to Ask Your Doctor Drug Information from MedlinePlus

Alternate Title
Basic Trial Information
Trial Description
     Purpose
     Eligibility
     Treatment/Intervention
Trial Contact Information
Related Information
Registry Information

Alternate Title

Genetic Study of Mutations in Participants Previously Enrolled in NCI-99-C-0053 Who Have von Hippel-Lindau (VHL) Syndrome or Who Are at Risk for VHL Syndrome

Basic Trial Information

Phase	Type	Status	Age	Sponsor	Protocol IDs
No phase specified	Genetics	Completed	Adult	NCI	NCI-03-C-0148 NCT00075348

Trial Description

Purpose:

The identification of gene mutations in individuals who have or are at risk for von Hippel-Lindau syndrome may allow doctors to better determine the genetic processes involved in the development of cancer.

This genetic study is finding gene mutations in participants with von Hippel-Lindau syndrome or who are at risk for developing von Hippel-Lindau syndrome.

Eligibility:

Eligibility criteria include the following:

• Adult
• Previously enrolled in clinical trial NCI-99-C-0053
• For more information about the eligibility criteria for this trial, refer to the Health Professional version.

Final eligibility for a clinical trial is determined by the health professionals conducting the trial.

Treatment/Intervention:

A sample of participants' blood or cheek cells will be collected and analyzed. Participants may receive genetic counseling and/or the results of genetic testing.

Important:

For more details about this trial, refer to the Health Professional version of the trial summary.

If you are interested in participating in a clinical trial, contact your doctor for a referral or call a trial contact person listed below. You may see the same contact person listed at more than one site, however, if you call the number listed you can ask to speak to the study coordinator or person involved with the specific trial you are interested in. If you have questions about cancer or clinical trials, call the Cancer Information Service at 1-800-4-CANCER (1-800-422-6237). General information about clinical trials, including risks, benefits, and costs, can be found on NCI's Web site.

Trial Contact Information

Trial Lead Organizations

NCI - Center for Cancer Research

William Linehan, MD, Protocol chair		Ph: 301-496-6353

Related Information

PDQ® clinical trial NCI-99-C-0053

Registry Information
Official Title		Genetic Mutation Analysis In A VHL Population
Trial Start Date		2003-12-31
Trial Completion Date		2008-12-23
Registered in ClinicalTrials.gov		NCT00075348
Date Submitted to PDQ		2003-04-11
Information Last Verified		2008-11-30

Back to Top